TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization

J Clin Invest. 2015 Feb;125(2):571-82. doi: 10.1172/JCI75183. Epub 2015 Jan 2.

Abstract

While 30%-70% of RSV-infected infants develop bronchiolitis, 2% require hospitalization. It is not clear why disease severity differs among healthy, full-term infants; however, virus titers, inflammation, and Th2 bias are proposed explanations. While TLR4 is associated with these disease phenotypes, the role of this receptor in respiratory syncytial virus (RSV) pathogenesis is controversial. Here, we evaluated the interaction between TLR4 and environmental factors in RSV disease and defined the immune mediators associated with severe illness. Two independent populations of infants with RSV bronchiolitis revealed that the severity of RSV infection is determined by the TLR4 genotype of the individual and by environmental exposure to LPS. RSV-infected infants with severe disease exhibited a high GATA3/T-bet ratio, which manifested as a high IL-4/IFN-γ ratio in respiratory secretions. The IL-4/IFN-γ ratio present in infants with severe RSV is indicative of Th2 polarization. Murine models of RSV infection confirmed that LPS exposure, Tlr4 genotype, and Th2 polarization influence disease phenotypes. Together, the results of this study identify environmental and genetic factors that influence RSV pathogenesis and reveal that a high IL-4/IFN-γ ratio is associated with severe disease. Moreover, these molecules should be explored as potential targets for therapeutic intervention.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bronchiolitis, Viral* / genetics
  • Bronchiolitis, Viral* / immunology
  • Bronchiolitis, Viral* / pathology
  • Disease Models, Animal
  • Environmental Exposure / adverse effects*
  • Female
  • GATA3 Transcription Factor / genetics
  • GATA3 Transcription Factor / immunology
  • Genotype*
  • Humans
  • Infant
  • Infant, Newborn
  • Interferon-gamma / genetics
  • Interferon-gamma / immunology
  • Interleukin-4 / genetics
  • Interleukin-4 / immunology
  • Lipopolysaccharides / toxicity*
  • Male
  • Mice
  • Respiratory Syncytial Virus Infections* / genetics
  • Respiratory Syncytial Virus Infections* / immunology
  • Respiratory Syncytial Virus Infections* / pathology
  • Respiratory Syncytial Viruses*
  • T-Box Domain Proteins / genetics
  • T-Box Domain Proteins / immunology
  • Th2 Cells / immunology*
  • Th2 Cells / pathology
  • Toll-Like Receptor 4* / genetics
  • Toll-Like Receptor 4* / immunology

Substances

  • GATA3 Transcription Factor
  • GATA3 protein, human
  • Gata3 protein, mouse
  • IFNG protein, human
  • IL4 protein, human
  • Lipopolysaccharides
  • T-Box Domain Proteins
  • T-box transcription factor TBX21
  • TLR4 protein, human
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Interleukin-4
  • Interferon-gamma